ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 107 filers reported holding ERASCA INC in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,294 | +154.9% | 54,464 | +257.2% | 0.00% | – |
Q2 2023 | $42,087 | -95.0% | 15,249 | -94.6% | 0.00% | – |
Q1 2023 | $844,498 | +1559.4% | 280,564 | +2276.1% | 0.00% | – |
Q4 2022 | $50,892 | -52.0% | 11,808 | -12.9% | 0.00% | – |
Q3 2022 | $106,000 | +63.1% | 13,557 | +16.9% | 0.00% | – |
Q2 2022 | $65,000 | -59.4% | 11,599 | -37.8% | 0.00% | – |
Q1 2022 | $160,000 | – | 18,658 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 11,055,554 | $47,649,438 | 12.20% |
EDBI Pte Ltd | 888,888 | $3,831,107 | 4.88% |
Cormorant Asset Management, LP | 10,813,246 | $46,605 | 3.12% |
AH Equity Partners LSV II, L.L.C. | 312,500 | $1,346,875 | 1.64% |
GREAT POINT PARTNERS LLC | 1,538,461 | $6,630,767 | 1.30% |
Artal Group S.A. | 4,710,682 | $20,303 | 1.13% |
PFM Health Sciences, LP | 4,797,460 | $20,677,053 | 0.74% |
Ghisallo Capital Management LLC | 929,316 | $4,005,352 | 0.71% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 462,972 | $1,995,409 | 0.38% |
CVI Holdings, LLC | 376,716 | $1,623,646 | 0.21% |